******UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 10-QSB**

**X**Quarterly report under section 13 or 15(d) of the Securities Exchange Act of 1934 for the period
ended September 30, 2001.

____Transition report under section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition
period from ______ to ______.

**AGRONIX, INC.**

(Exact name of registrant as specified in its charter)

|Florida                                        | 0-15893                  | 13-4025362                          
|---------------------------------------------- | ------------------------ | ------------------------------------
|(State or other jurisdiction of
incorporation) | (Commission File Number) | (IRS Employer Identification
Number)

|1666 West 75th Avenue

Vancouver, B.C., Canada | V6P6G2    
|---------------------------------------------- | ----------
|(Address of principal executive offices)       | (Zip Code)

Registrant's telephone number, including area code:  (604) 714-1606

RCA Trading Co., Inc., 515 Madison Avenue, 21st Fl.  New York, NY  10022

(Former name or former address, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes. X  No...

Applicable only to issuers involved in bankruptcy proceedings during the past five years.

Check whether the issuer has filed all documents and reports required to be filed by Section 12, 13 or
15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.  Yes .....
No .....

Applicable only to corporate issuers

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest
practicable date:  At September  30, 2001, there were 9,199,157 shares outstanding.

Transitional Small Business Disclosure Format (Check one):  Yes .....     No ..X..

PART 1 - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS AND EXHIBITS

**Contents**

****

Consolidated Balance Sheet

Consolidated Statement of Operations

Consolidated Statement of Cash Flows

Consolidated Statement of Stockholders' Equity

Notes to the Consolidated Financial Statements

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

(A Development Stage Company)

**CONSOLIDATED BALANCE SHEET**

(Expressed in U.S. Dollars)

(Unaudited)

**AS AT SEPTEMBER 30, 2001**

**ASSETS**

|                                    | **September 30**   | ******December 31**
|----------------------------------- | ------------------ | -------------------
|                                    | **2001******       | ******2000**       
|**CURRENT**                         |                    |                    
|Cash                                | $46,677            | $95,040            
|Interest receivable                 | 51                 | 403                
|                                    | 46,728             | 95,443             
|**CAPITAL ASSETS**(Note 4)          | 5,705              | 2,265              
|**INVESTMENT IN AND ADVANCES TO**   |                    |                    
|**3884171 CANADA INC.**(Note 5)**** | ********91,123**** | ********6,567      
|                                    | $143,556           | $104,275           

**LIABILITIES**

|**CURRENT**                                    |         |       
|---------------------------------------------- | ------- | ------
|Accounts payable and accrued liabilities       | $24,949 | $9,265
|Due to companies with common director (Note 6) | 70,410  | 7,000 
|Due to shareholder                             | 666     | -     
|                                               | 96,025  | 16,265

**STOCKHOLDERS' EQUITY**

|**CAPITAL STOCK**(Note 7) |  | 
|------------------------- |  | 
|**Authorized:**           |  | 

25,000,000 common shares with a par value of $0.001 per share

10,000,000 preferred shares with a par value of $0.001 per share

|**Issued and outstanding:**               |                         |                  
|----------------------------------------- | ----------------------- | -----------------
|9,199,157 (2000: 6,622,250) common shares | 9,199                   | 6,622            
|Additional paid in capital                | 1,528,290               | 799,127          
|Shares subscribed                         | -                       | 22,500           
|****                                      | 1,537,489               | 828,249          
|**DEFICIT ACCUMULATED DURING THE**        | ********                | ********         
|**DEVELOPMENT STAGE**                     | ********(1,489,958)**** | ********(740,239)
|****                                      | 47,531                  | 88,010           
|                                          | $143,556                | $104,275         

Continuance of operations (Note 1)

Commitments (Note 9)

See accompanying notes to the consolidated financial statements.

******AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

**(A Development Stage Company)**

**CONSOLIDATED STATEMENT OF OPERATIONS**

**(Expressed in U.S. Dollars)**

**(Unaudited)**

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2001**

|********                           | ******Cumulative**      | ********          | ********            | ********            | ********           
|---------------------------------- | ----------------------- | ----------------- | ------------------- | ------------------- | -------------------
|****                               | ******From Inception**  | **For the Three** | **For the Three**   | **For the Nine**    | **From Inception** 
|                                   | ******Jan 20, 2000 to** | **Months Ended**  | **Months Ended**    | **Months Ended**    | **Jan 20, 2000 to**
|                                   | **September 30**        | **September 30**  | **September 30**    | **September 30**    | **September 30**   
|                                   | **2001**                | ******2001**      | ******2000**        | ******2001**        | ******2000**       
|**INTEREST EARNED**                | $2,253                  | $174              | $253                | $1,075              | $2,745             
|**EXPENSES**                       |                         |                   |                     |                     |                    
|Compensation expense for           |                         |                   |                     |                     |                    
|stock options                      | 409,800                 | 111,300           | 50,750              | 228,550             | 116,000            
|Consulting                         | 675,871                 | 281,739           | 77,195              | 379,701             | 247,907            
|Depreciation                       | 986                     | 297               | 78                  | 674                 | 234                
|Office and general                 | 35,440                  | 5,710             | 5,652               | 19,739              | 14,874             
|Professional fees                  | 82,668                  | 9,242             | 6,503               | 39,086              | 27,743             
|Rent                               | 13,463                  | 3,836             | -                   | 10,973              | -                  
|Research and development           | 150,000                 | -                 | -                   | -                   | -                  
|Shareholder
communications         | 5,481                   | 1,841             | -                   | 2,968               | -                  
|Share of loss in 3884171           |                         |                   |                     |                     |                    
|Canada Inc. (Note 5)               | 20,000                  | -                 | -                   | 20,000              | -                  
|Telephone and internet             | 9,809                   | 2,098             | -                   | 7,092               | -                  
|Travel and promotion               | 88,693                  | 13,010            | 5,440               | 42,011              | 36,099             
|                                   | 1,492,211               | 429,073           | 145,618             | 750,794             | 442,857            
|**NET LOSS**                       | $(1,489,958)            | $(428,899)        | $(145,365)          | $(749,719)          | $(440,112)         
|****                               | ****                    | ********          | ********            | ********            | ********           
|****Weighted average common        | ****                    | ********          | ********            | ********            | ********           
|shares outstanding                 |                         | ****8,954,543     | ****6,620,857       | ****8,100,804       | ****6,183,921      
|****Basic and diluted loss per**** | ********                | ********          | ****                | ****                | ****               
|share                              |                         | ****$(0.05)****   | ********$(0.02)**** | ********$(0.09)**** | ********$(0.07)    

See accompanying notes to the consolidated financial statements.

****

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

(A Development Stage Company)****

**CONSOLIDATED STATEMENT OF CASH FLOWS**

**(Expressed in U.S. Dollars)**

**(Unaudited)**

**FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2001**

|********                                                        | **Cumulative******   | ****             | ********            
|--------------------------------------------------------------- | -------------------- | ---------------- | --------------------
|****                                                            | **From Inception**   | **For the Nine** | **From Inception**  
|                                                                | **January 20, 2000** | **Months Ended** | **January 20, 2000**
|                                                                | **to September 30**  | **September 30** | **to September 30** 
|                                                                | **2001******         | ******2001****** | ******2000**        
|**Cash derived from (applied to):**                             | ****                 |                  |                     
|**********OPERATING**                                           | ********             | ********         | ********            
|Net Loss                                                        | $(1,489,958)         | $(749,719)       | $(440,112)          
|Depreciation                                                    | 986                  | 674              | 234                 
|Research and development expenses paid                          |                      |                  |                     
|through issuance of common shares (Note 8)                      | 150,000              | -                | 150,000             
|Compensation expense for stock options                          | 409,800              | 228,550          | 116,000             
|Share of loss in 3884171 Canada Inc. (Note 5)                   | 20,000               | 20,000           | -                   
|Rent paid through issuance of common                            |                      |                  |                     
|shares                                                          | 6,386                | 6,386            | -                   
|Consulting fees paid though the                                 |                      |                  |                     
|issuance of comon shares                                        | 250,339              | 250,339          | -                   
|Change in non-cash working capital                              |                      |                  |                     
|Interest receivable                                             | (51)                 | 352              | -                   
|Payables and accruals                                           | 11,848               | 2,583            | 3,000               
|                                                                | (640,650)            | (240,835)        | (170,878)           
|**FINANCING**                                                   |                      |                  |                     
|Advances under a credit facility with a                         |                      |                  |                     
|company with director in common                                 | 191,772              | 63,410           | -                   
|Repayments of credit facility with a                            |                      |                  |                     
|company with director in common                                 | (121,362)            | -                | -                   
|Advances from shareholder                                       | (13,601)             | (13,601)         | -                   
|Shares issued for cash                                          | 748,332              | 251,333          | 451,568             
|                                                                | 805,141              | 301,142          | 451,568             
|**INVESTING**                                                   |                      |                  |                     
|Acquisition of capital assets                                   | (6,691)              | (4,114)          | (2,577)             
|Intellectual property                                           | -                    | -                | (202,350)           
|Investment in and advances to 3884171 Canada Inc.               | (111,123)            | (104,556)        | -                   
|                                                                | (117,814)            | (108,670)        | (204,927)           
|****Increase (decrease) in cash                                 | 46,677               | (48,363)         | 75,763              
|**Cash,** beginning of period                                   | -                    | 95,040           | -                   
|**Cash,** end of period                                         | $46,677              | $46,677          | $75,763             
|**Non-cash financing transactions not included in cash
flows:** |                      |                  |                     
|Shares issued to acquire research and development               | $150,000             | $-               | $150,000            
|Compensation expense for stock options                          | $409,800             | $228,550         | $116,000            
|Shares issued for premises lease                                | $6,386               | $6,386           | $-                  
|Shares issued for consulting services provided                  | $250,339             | $250,339         | $-                  



See accompanying notes to the consolidated financial statements.

****

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

**(A Development Stage Company)**

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY**

**(Expressed in U.S. Dollars)**

**(Unaudited)**

**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2001**

|********                                    | ********         | ********     | ********         | ********       | ******Deficit** | ******** 
|------------------------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ---------
|****                                        |                  |              | **************** | ****           | **Accumulated** | ****     
|                                            | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****     
|                                            | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****     
|                                            | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total**
|Shares issued for cash                      |                  |              |                  |                |                 |          
|************************at $0.001 per share | $5,250,000       | $5,250       | $-               | $-             | $-              | $5,250   
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $0.30 per share                          | 40,000           | 40           | 7,960            | -              | -               | 8,000    
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $1.00 Cdn per share                      | 1,000,000        | 1,000        | 337,287          | -              | -               | 338,287  
|Shares issued for cash                      |                  |              |                  |                |                 |          
|at $1.00 Cdn per share                      | 182,250          | 182          | 122,780          | -              | -               | 122,962  
|Shares issued to acquire                    |                  |              |                  |                |                 |          
|research and                                |                  |              |                  |                |                 |          
|development (Note 8)                        | 150,000          | 150          | 149,850          | -              | -               | 150,000  
|Shares subscribed at $1.00                  |                  |              |                  |                |                 |          
|U.S. cash per share                         | -                | -            | -                | 22,500         | -               | 22,500   
|Compensation expense                        |                  |              |                  |                |                 |          
|for stock options                           | -                | -            | 181,250          | -              | -               | 181,250  
|Net loss                                    | -                | -            | -                | -              | (740,239)       | (740,239)
|Balance, December 31, 2000                  | 6,622,250        | 6,622        | 799,127          | 22,500         | (740,239)       | 88,010   
|Acquisition of AWR on                       |                  |              |                  |                |                 |          
|March 26, 2001 (Note 3)                     | 6,622,250        | 6,622        | (33,990)         | -              | -               | (27,368) 
|Reverse merger adjustment                   | (4,939,000)      | (4,939)      | 4,939            | -              | -               | -        
|Shares subscribed as $1.00                  |                  |              |                  |                |                 |          
|U.S. cash per share                         | -                | -            | -                | 33,400         | -               | 33,400   
|Compensation expense                        |                  |              |                  |                |                 |          
|for stock options                           | -                | -            | 76,750           | -              | -               | 76,750   
|Net loss                                    | -                | -            | -                | -              | (177,641)       | (177,641)
|Balance, March 31, 2001                     | 8,305,500        | 8,305        | 846,826          | 55,900         | (917,880)       | (6,849)  
|Subscribed shares issued at                 |                  |              |                  |                |                 |          
|$1.00 Cdn per share                         |                  |              |                  |                |                 |          
|(subscription agreement                     |                  |              |                  |                |                 |          
|revised from $1.00 U.S.                     |                  |              |                  |                |                 |          
|to $1.00 Cdn)                               | 78,850           | 79           | 52,321           | (55,900)       | -               | (3,500)  
|Shares issued for premises                  |                  |              |                  |                |                 |          
|lease at $1.00 Cdn per                      |                  |              |                  |                |                 |          
|share                                       | 3,920            | 4            | 2,546            | -              | -               | 2,550    
|Shares issued for cash at                   |                  |              |                  |                |                 |          
|$1.00 Cdn per share                         | 219,600          | 220          | 111,126          | -              | -               | 111,346  
|Shares subscribed at $1.00                  |                  |              |                  |                |                 |          
|Cdn cash per share                          | -                | -            | -                | 6,917          | -               | 6,917    
|Compensation expense for                    |                  |              |                  |                |                 |          
|stock options                               | -                | -            | 40,500           | -              | -               | 40,500   
|Net loss                                    | -                | -            | -                | -              | (143,179)       | (143,179)
|Balance, June 30, 2001                      | 8,607,870        | $8,608       | $1,053,319       | $6,917         | $(1,061,059)    | $7,785   

See accompanying notes to the consolidated financial statements.

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

**(A Development Stage Company)**

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY**

**(Expressed in U.S. Dollars)**

**(Unaudited)**

**FOR THE PERIOD FROM INCEPTION (JANUARY 20, 2000) TO SEPTEMBER 30, 2001**

|************                 | ********         | ********     | ********         | ********       | ******Deficit** | ******** 
|---------------------------- | ---------------- | ------------ | ---------------- | -------------- | --------------- | ---------
|****                         |                  |              | **************** | ****           | **Accumulated** | ****     
|                             | ******Common**   | **Common**   | **Additional**   | ****           | **During the**  | ****     
|                             | ******Shares**   | **Shares**   | **Paid-In**      | **Shares**     | **Development** | ****     
|                             | ******(Number)** | **(Amount)** | **Capital**      | **Subscribed** | **Stage**       | **Total**
|                             |                  |              |                  |                |                 |          
|Balance, June 30, 2001       | 8,607,870        | $8,608       | $1,053,319       | $6,917         | $(1,061,059)    | $7,785   
|Subscribed shares cancelled  | -                | -            | -                | (6,917)        | -               | (6,917)  
|Shares issued for cash       |                  |              |                  |                |                 |          
|at $0.50 Cdn per share       | 60,000           | 60           | 19,028           | -              | -               | 19,088   
|Shares issued for cash       |                  |              |                  |                |                 |          
|at $1.00 Cdn per share       | 134,407          | 134          | 87,365           | -              | -               | 87,499   
|Shares issued for consulting |                  |              |                  |                |                 |          
|services at $1.00 Cdn        |                  |              |                  |                |                 |          
|per share                    | 391,000          | 391          | 253,448          | -              | -               | 253,839  
|Shares issued for premises   |                  |              |                  |                |                 |          
|lease at $1.00 Cdn per       |                  |              |                  |                |                 |          
|share                        | 5,880            | 6            | 3,830            | -              | -               | 3,836    
|Compensation expense         |                  |              |                  |                |                 |          
|for stock options            | -                | -            | 111,300          | -              | -               | 111,300  
|Net loss                     | -                | -            | -                | -              | (428,899)       | (428,899)
|Balance, September 30, 2001  | 9,199,157        | $9,199       | $1,528,290       | $-             | $(1,489,958)    | $47,531  

See accompanying notes to the consolidated financial statements.

****

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

**(A Development Stage Company)**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**September 30, 2001**

**1.	OPERATIONS AND GOING CONCERN**

The company was incorporated under the laws of Florida, U.S.A. on May 6, 1996 as RCA Trading Co. The
company changed its name to Agronix, Inc. on June 18, 2001.

Pursuant to a share exchange agreement entered into on October 16, 2000 and closed on March 26, 2001,
between the shareholders of the Agronix and shareholders of a private company, American Waste
Recovery, Inc. ("AWR"), the company purchased all of the outstanding shares of AWR.  AWR was
incorporated under the laws of Nevada, U.S.A. on January 20, 2000 as American Bio Recovery, Inc.; on
January 26, 2000, its name was changed to American Waste Recovery, Inc.  The consideration for this
acquisition was the issuance by the company of 6,622,250 common shares (Note 3).

As a result of this transaction, AWR has become a wholly-owned subsidiary of Agronix and the former
shareholders of AWR in turn became owners of the majority of the issued and outstanding shares of
Agronix.  Since the former shareholders of AWR have acquired control of Agronix through this
transaction, it is considered a reverse acquisition and these financial statements are presented from the
perspective of AWR (the accounting parent in this transaction).  These financial statements present the
consolidated results of operations from AWR's date of incorporation to September 30, 2001 including the
results of operations of Agronix since March 26, 2001.

AWR and Agronix have had limited activity since their inception.  No significant revenues have been
realized and planned principal operations have not yet commenced.  AWR is engaged in the acquisition
and development of technologies that convert organic residues into agricultural products such as growth
substrates, organically-based plant nutrients and soil amendments and also chemicals and commodities for
agriculture and industry.

Agronix does not have an established source of revenue sufficient to cover its operating costs and allow it
to continue as a going concern.  It is the intention of the company to seek additional financing through
private and public placements of its common stock and to seek commercial alliances to access market
opportunities.

**2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

These unaudited consolidated financial statements are presented in accordance with accounting principles
generally accepted in the United States and have been prepared on the same basis as the annual audited
financial statements.  In the opinion of management, these unaudited consolidated financial statements
reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation for
each of the periods presented.  The results of operations for interim periods are not necessarily indicative
of results to be achieved for full fiscal years.

As contemplated by the Securities and Exchange Commission (SEC) under Rule 10-01 of Regulation S-X,
the accompanying consolidated financial statements and related footnotes have been condensed and do not
contain certain information that would be included in the company's annual consolidated financial
statements and footnotes.  For further information, refer to the consolidated financial statements and
related footnotes for the year ended December 31, 2000 included in the company's Annual Report on Form
10-KSB.

**CONSOLIDATION**

These financial statements include the accounts of the company and its wholly-owned subsidiary, AWR.

**ACCOUNTING FOR STOCK OPTIONS**

In October 1995, the FASB issued Statement of Financial Accounting Standards No. 123, Accounting for
Stock-Based Compensation ("SFAS No. 123"), which requires entities to calculate the fair value of stock
awards granted to employees.  This statement provides entities with the option of electing either to expense
the fair value of employee stock-based compensation or to continue to recognize compensation expense under
previously existing accounting pronouncements set out in APB 25 and to provide pro-forma disclosures of net
earnings (loss) and, if presented, earnings (loss) per share, as if the above-referenced fair value method of
accounting was used in determining compensation expense.

The company has elected to account for stock-based employee or director compensation arrangements in
accordance with Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees
("APB No. 25").

Stock options issued to non-employees are recorded at the fair value of the services received or at the fair value
of the options issued, whichever is more reliably measurable.  Compensation is charged to expense over the
shorter of the term of service or the vesting period.

The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options
and warrants which have no vesting restrictions and are fully transferable.  In addition, option valuation models
require the input of highly subjective assumptions, including the expected stock price volatility.  Because the
company's employee stock options and warrants have characteristics significantly different from those of
traded options, and because changes in the subjective input assumptions can materially affect the fair value
estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure
of the fair value of its employee stock options.

**CAPITAL ASSETS**

Capital assets are recorded at cost less accumulated depreciation.  Depreciation is recorded on the straight-line
method at the following rates:

****

|Office equipment   | 20	% | straight line
|------------------ | ---- | -------------
|Computer equipment | 30	% | straight line
|Computer software  | 100% | straight line

**INVESTMENTS**

****	The company uses the equity method to account for investments in companies and other business ventures over
which it exercises significant influence.

**TECHNOLOGY**

The company capitalizes the acquisition costs of technologies where their technological feasibility has been
established.

**3.	ACQUISITION**

On March 26, 2001, the company acquired AWR in a share-for share exchange where the company issued
6,622,250 of its common shares in exchange for all the issued and outstanding shares of AWR.  The
acquisition has been accounted for by the purchase method with AWR as the acquirer as follows:

**Identifiable liabilities acquired at estimated fair market value:**Assets
$-Less: current liabilities
(27,368)$(27,368)**Consideration:**6,225,200 common shares
$(27,368)**4.	CAPITAL ASSETS**

****
********
********
******Net**
******Net******
********
******Accumulated**
******September 30**
******December 31******
******Cost**
******Amortization**
******2001**
******2000**Office equipment
$1,484
$371
$1,113
$1,336Computer equipment
2,476
565
1,911
929Computer software
133
50
83
-Option to purchase land
2,598
-
2,598
-$6,691
$986
$5,705
$2,265**5.  INVESTMENT IN AND ADVANCES TO 3887141 CANADA INC.**

Pursuant to an agreement entered into by the company and Bio-Max Inc. ("Bio-Max") (a Quebec City,
Canada based developer of organic waste processing plants), Bio-Max has created a subsidiary (3884171
Canada Inc. ("Newco")) in which the company owns 20% of the issued and outstanding common shares.
Newco has been established to further the development and commercialization of Bio-Max's "Robo III"
technology.

Under the terms of the agreement:

(a) Bio-Max contributed the Robo III technology as its capital contribution to Newco.  In         exchange for
this contribution, Bio-Max received an 80% interest in Newco.

(b) The company paid $20 Cdn. and will utilize its soil and organic matter expertise and intellectual property
in exchange for a 20% interest in Newco.  The company has commited to contribute $225,000 Cdn. to Newco
to further the Robo III technology.

(c) Bio-Max has given the company a three year option to purchase a further 30% of Newco for $1,500,000
Cdn.

(d) The company and Bio-Max have given each other a right of first refusal to match any offer to purchase any
shares of Newco owned by each of them.

(e) Bio-Max shall retain the rights to market the Robo III technology in Francophone countries with the
company retaining marketing rights in the balance of the world.

During 2000, the company made an initial deposit of $10,000 Cdn.  During the nine months ended September
30, 2001, the company advanced $164,000 Cdn. to Newco.  As the company has significant influence over
Newco, this investment has been accounted for by the equity method.  The company's investment in and
advances to Newco have been accounted for as follows:

****
********
******September 30**
******December 31************2001**
******2000**Investment in Newco
$13
$-Advances to Newco, non-interest bearing, no stated terms ofrepayment
111,110
6,567Share of Newco's losses up to September 30, 2001
$(20,000)
$-$91,123
$6,567**6.	DUE TO COMPANY WITH COMMON DIRECTOR**

****
********
******September 30**
******December 31************2001**
******2000**Revolving credit facility - unsecured, non-interest bearing, principaldue in one year on a revolving basis
$7,000
$7,000Demand loan - unsecured, principal in the amount of $100,000Cdn; 12% per annum simple interest; interest payable monthly;principal and accrued interest due by June 30, 2002
63,410
-$70,410
$7,000**7.	CAPITAL STOCK**

On June 11, 2001 the company amended its Articles of Incorporation with respect to the authorized
number of shares.  The authorized number of common shares was changed from 20,000,000 common
shares to 25,000,000 common shares and the authorized number of preferred shares was changed from
5,000,000 preferred shares to 10,000,000 preferred shares.

**STOCK OPTIONS**

The following table summarizes information about outstanding and exercisable share options at September 30,
2001:

**Options Outstanding**
**Options Exercisable****************Average**
**Weighted**
****
**Weighted****************Remaining**
**Average**
****
**Average************Excercise**
**Contractual**
**Excercise**
****
**Excercise****Number**
****
**Price**
**Life**
**Price**
**Number**
**Price****Outstanding**
**Grant Date**
**Per Share**
**(In Years)**
**Per Share**
**Exercisable**
**Per Share******420,000****
****01/27/00****
****$0.50
****4.33
****$0.50
****420,000
****$0.50200,000
01/28/00
0.50
4.33
0.50
200,000
0.50250,000
02/17/00
0.50
4.39
0.50
250,000
0.50250,000
08/04/00
0.50
4.85
0.50
250,000
0.5075,000
10/30/00
0.67
5.08
0.67
75,000
0.67200,000
01/17/01
1.00
4.30
1.00
150,000
1.0040,000
07/03/01
1.00
5.76
1.00
10,000
1.00500,000
07/09/01
0.50
4.78
0.50
125,000
0.501,935,000




1,480,000

The company granted options to purchase 422,500 shares of the company's common stock to consultants
during the nine months ended September 30, 2001.  Compensation expense of $228,550 related to these
options has been recorded.

The company also granted options to purchase 168,750 shares of the company's common stock to directors
and employees during the nine months ended September 30, 2001.  No expense has been recorded related
to these options.

**PERFORMANCE SHARES**

On January 27, 2000, 500,000 performance shares were issued into escrow for the company's President and
C.E.O.  For each $0.25 of cumulative cash flow generated by the company from its operations, one
performance share will be released from escrow.  All shares are in escrow at September 30, 2001.

**LOSS PER SHARE**

The company follows Statement of Financial Standard No. 128 to calculate earnings per share.  Basic loss
per share is computed using the weighed effect of all common shares issued and outstanding.  Fully diluted
earnings per share has not been presented as the effect on basic earnings per share is anti-dilutive.

**8.  RESEARCH AND DEVELOPMENT**

During 2000, AWR acquired certain soil and organic matter expertise and intellectual property from an
unrelated organic residue consultant based in Ottawa, Canada.  The consideration for this acquisition was
150,000 AWR common shares issued at an estimate of their fair value of $1.00.  As the research and
development acquired has yet to be proven commercially, its acquisition has been expensed.  All further
expenditures to develop the underlying process and technology will be expensed until it reaches the point
where technological feasability can be established and it can be commercially exploited.

**9.  COMMITMENTS**

**Collaborative Research and Development Agreement**

The company has entered into a preliminary collaborative research and development agreement with
Carlton University to conduct research and development for the transformation of bio-solids into
commodity chemicals and agricultural products.  Upon execution of a formal agreement, the company will
contribute approximately $90,000 per year in cash for five years. The Company will own any new
technologies and/or intellectual property arising out of these research and development activities.  No
expenditures have been made under this agreement.

**Marketing Agreement**

During the period the company had entered into a marketing agreement with a U.K. registered company
whereby the company had committed to provide exclusive rights to introduce the company's technology
into certain countries and territories.  Under the agreement, Agronix had agreed to pay $150,000 per
completed project.  The agreement was to remain in place until September 16, 2005 with an automatic
extension to September 16, 2010.  Due to the U.K. registered company's failure to fulfill its obligations, the
agreement has been terminated.

**Licensing Agreement**

The company has entered into a licensing agreement with a U.K. registered company whereby the company
has committed to provide exclusive rights to introduce the company's technology throughout Europe.
Under the agreement the company has received a convertible loan note, the principal amount of $8,000,000
with an agreed value of GBP 5,673,759; non-interest bearing and convertible on July 21, 2002 into
2,466,852 shares of non-diluted common shares of the licensee, or immediately upon the licensee being
listed on any recognized stock exchange, if this occurs prior to July 21, 2002.

This transaction has not been recorded in the financial statements, as there is uncertainty as to the
collectibility of the $8,000,000 note.  In addition, the fair market value of the 2,466,852 common shares
which would be received on conversion can not be readily determined.

**Option to purchase land**

The company has acquired an option to purchase a 73 acre parcel of land in the Fraser Valley region of
British Columbia, Canada, on which it intends to construct its initial pilot plant in Western Canada.  Under
the agreement, the company has agreed to pay $2,000 Cdn. per month to extend the land purchase option to
February 18, 2002.   The agreed purchase price of the land is $1,800,000 Cdn.  The company is required to
make a payment of $100,000 Cdn. by January 30, 2002 to secure the purchase  agreement.

******10.  INCOME TAXES**

At September 30, 2001, the company has net operating losses carried forward of approximately $700,000
that may be offset against future taxable income to 2020.  No future tax benefit has been recorded in the
financial statements, as the company believes that it is more likely than not that the carryforwards will
expire unused.  Accordingly, the potential tax benefits of the loss carry-forwards are offset by a valuation
allowance of the same amount.

**11.  RELATED PARTY TRANSACTIONS**

During the nine months ended September 30, 2001, the company paid $44,928 in consulting fees to its
president and C.E.O. and $304,517 to other shareholders as consulting fees.  The consulting fees of
$304,517  paid to other shareholders include cash payments of $50,678 and 341,000 common shares
valued at $253,839. The company also paid rent of $4,587 cash to a company controlled by its president,
and rent of  $6,387 to a shareholder by way of the issuance of 9,800 shares valued at $1.00 Cdn. per share.



**ITEM  2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION**

The following discussion contains certain statements that may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.  Any statements that refer to
expectations, projections or other characterization of future events or circumstances, and especially those
which include variations of the words "believes," "intends," "estimates," "anticipates," "expects," "plans,"
or similar words or variations thereof, are likely to be forward-looking statements, and as such, are likely to
concern matters involving risk, uncertainty, unpredictability and other factors that could materially and
adversely affect the outcome or results indicated by or inferred from the statements themselves. Therefore,
the reader is advised that the following discussion should be considered in light of the discussion of risks
and other factors contained in this Form 10QSB and in the Company's other filings with the Securities and
Exchange Commission, and that no statements contained in the following discussion or in this Form
10QSB should be construed as a guarantee or assurance of future performance or future results.

****Introduction

During the second quarter, the Company held a special shareholders meeting which approved a name
change from RCA Trading Co. d.b.a. American Waste Recovery, Inc. to Agronix, Inc.  This name change
compliments the market/industry in which the company does business.  Along with the name change, the
shareholders approved an increase in the authorized common stock from 10,000,000 to 25,000,000 shares
and authorized 10,000,000 shares of preferred stock.

Plan of Operations

Agronix, Inc. plans to engage in the business of acquiring and developing technologies

that convert organic residues into agricultural products such as growth substrates, organically based plant
nutrients and soil amendments.  The Company will also engage in the business of developing technologies
that are used in the recovery of chemicals and commodities for agriculture and industry.

The Company remains in the development stage and does not have an established source of revenue
sufficient to cover its operating costs. As of September 30, 2001, the Company had cash on hand of
$46,677, which is not a sufficient amount to allow it to pay its operating expenses and carry out its plan of
operation for the next for the next twelve months. Therefore, it is the Company's intention to seek
additional financing through private and public placements of its common stock and to seek commercial
alliances to access market opportunities.

Pursuant to an agreement entered into by the Company and BIOMAX Inc. ("Biomax") (a Quebec City,
Canada based developer of organic waste processing plants), the Company and Biomax have agreed to
create a subsidiary ("Newco") to further the development and commercialization of Biomax's "Robo III"
technology. During 2000, the Company made the initial deposit of $10,000 Cdn. required under this
agreement. Under the terms of the agreement Biomax will contribute the Robo III technology as its capital
contribution to Newco. In exchange for this contribution, Biomax will receive an 80% interest in Newco.
The Company will contribute $225,000 Cdn. and utilize its soil and organic matter expertise and
intellectual property in Newco in exchange for a 20% interest. The parties have agreed to apply the
$10,000 Cdn. deposit made in 2000 to this $225,000 contribution.  During the second quarter, the
Company made two additional payments, totalling Cdn. $149,000, leaving a remaining balance of Cdn.
$65,000.

The Company is presently working in the British Columbia, Fraser Valley, Abbottsford Region to locate its
first 50,000-ton per year bioconversion plant.  Subsequent to the end of the first quarter, the Company
located and contracted for the acquisition of 73-acre parcel of land for a purchase price of $1,800,000 Cdn.
The Company has negotiated a purchase option of Cdn $2,000 per month till October 15, 2001to preserve
its cash flow.  The Company is required to make a payment of $100,000 Cdn. by January 30, 2002 to
secure the purchase agreement.

The Company estimates that it will require funding of approximately $7,500,000 Cdn to complete
construction of the proposed Abbottsford plant. The Company has entered into discussions with the Farm
Credit Corporation (FCC) of Canada to provide 100% financing for the Abbottsford plant and all
subsequent plants to be constructed in Canada, but there is no assurance that this funding will be available.
In the event funding is available from FCC, it is expected to be provided through a joint venture
partnership that is partly owned by farmers and partly owned by the Company.

The Company has made a commitment to fund research carried on by Agriculture and Agri-Food Canada
in the amount of $150,000 Cdn per year for a period of 5 years, and to fund research being carried on by
Carlton University in the amount of $135,000 Cdn per year, for a period of 5 years. The Company will own
any new technologies and/or intellectual property arising out of these research and development activities.

The Company is currently continuing a private placement offering of up to 1,000,000 shares of common
stock at a price of $1.00 per share. In addition, the Company has a commitment for Epson Investment
Services N.V. to seek to raise a minimum of $5,000,000 and a maximum of $10,000,000 at $1.00 per share
contingent upon approval of the Company's shares for trading on the OTC Bulletin Board. There is no
assurance that these offerings will be successful, and there is no assurance as to when or whether the
Company's shares will be approved for trading on the OTC Bulletin Board.

****

PART II

ITEM 1.  LEGAL PROCEEDINGS

None.****

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS

******Issuance of Shares**

During the third quarter of 2001, the Company issued a total of 591,287 shares of common stock
in transactions which were exempt from registration under the Securities Act of 1933.  Of this
total, 194,407 shares were issued for cash received during the quarter, 391,000 shares which had
an equivalent cash value of USD $253,448 were issued for services received, and 5,880 shares
which had an equivalent cash value of USD $3,830 were issued in consideration of rental
payments for this third quarter made on the Company's behalf by a third party.

The shares were offered and sold on the Company's behalf by its officers and directors, and no
underwriting discounts or commissions were paid.  All of the shares were offered and sold outside
of he United States in offshore transactions which were exempt from registration under the
Securities Act of 1933 in reliance upon an exemption from registration provided by Regulation S
promulgated hereunder.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.****

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.****

No reports on Form 8-K were filed during the quarter ended September 30, 2001

****

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

**AGRONIX, INC.******

**(Formerly RCA Trading Co.)**

**(A Development Stage Company)**

****

By: /S/ BRIAN HAUFF

Brian Hauff, President, Chief Executive Officer and Director

By:/S/ PETER BARNETT

Peter Barnett, Director

By:/S/ PETER DRUMMOND

Peter Drummond

By:/S/ HENRI  DINEL

Henri Dinel, Director

Date: November 13 , 2001